CHICAGO, Nov 29 (Reuters) – The first breakthrough in 30 years of Alzheimer’s research is giving impetus to clinical trials of “cocktail” treatments that target the two distinctive proteins associated …
CHICAGO, Nov 29 (Reuters) – The first breakthrough in 30 years of Alzheimer’s research is giving impetus to clinical trials of “cocktail” treatments that target the two distinctive proteins associated …